Archives for July 12, 2023

← 2023
Acasti appoints WuXi to oversee STRIVE-ON trial

Acasti appoints WuXi to oversee STRIVE-ON trial

By Isabel Cameron

Acasti Pharma, a late-stage biopharma company with drug candidates addressing rare and orphan diseases, has selected WuXi Clinical Development to conduct its STRIVE-ON phase 3 safety trial for GTX-104, a novel injectable nimodipine formulation for...

Galmed uses AI to recruit underserved patients into clinical trials

Galmed uses AI to recruit underserved patients into clinical trials

By Jonathan Smith

The Israeli company Galmed Pharmaceuticals is deploying artificial intelligence (AI) tools developed by the U.S. company OnKai to help carry out clinical trials of a rare disease treatment in communities that have low access to healthcare.